These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 8828504)
1. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504 [TBL] [Abstract][Full Text] [Related]
2. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner. Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728 [TBL] [Abstract][Full Text] [Related]
3. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010 [TBL] [Abstract][Full Text] [Related]
4. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. Sasaoka T; Draznin B; Leitner JW; Langlois WJ; Olefsky JM J Biol Chem; 1994 Apr; 269(14):10734-8. PubMed ID: 8144662 [TBL] [Abstract][Full Text] [Related]
5. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. Kim B; Cheng HL; Margolis B; Feldman EL J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851 [TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219 [TBL] [Abstract][Full Text] [Related]
8. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors. Ishihara H; Sasaoka T; Ishiki M; Takata Y; Imamura T; Usui I; Langlois WJ; Sawa T; Kobayashi M J Biol Chem; 1997 Apr; 272(14):9581-6. PubMed ID: 9083103 [TBL] [Abstract][Full Text] [Related]
9. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes. Valverde AM; Lorenzo M; Pons S; White MF; Benito M Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931 [TBL] [Abstract][Full Text] [Related]
10. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Guvakova MA; Surmacz E Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Kim B; Leventhal PS; White MF; Feldman EL Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424 [TBL] [Abstract][Full Text] [Related]
12. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin. Pruett W; Yuan Y; Rose E; Batzer AG; Harada N; Skolnik EY Mol Cell Biol; 1995 Mar; 15(3):1778-85. PubMed ID: 7862167 [TBL] [Abstract][Full Text] [Related]
13. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites. Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530 [TBL] [Abstract][Full Text] [Related]
14. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797 [TBL] [Abstract][Full Text] [Related]
16. CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells. Galandrini R; Palmieri G; Piccoli M; Frati L; Santoni A J Exp Med; 1996 Jan; 183(1):179-86. PubMed ID: 8551221 [TBL] [Abstract][Full Text] [Related]
17. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis. Wada T; Sasaoka T; Ishiki M; Hori H; Haruta T; Ishihara H; Kobayashi M Endocrinology; 1999 Oct; 140(10):4585-94. PubMed ID: 10499514 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes. Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046 [TBL] [Abstract][Full Text] [Related]
19. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes. Mur C; Valverde AM; Kahn CR; Benito M Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675 [TBL] [Abstract][Full Text] [Related]
20. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase. Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]